Whole-body computed tomography as first-line imaging procedure to exclude cancer in patients with neurological suspicion of paraneoplastic syndromes: shall clinical practice adhere to recommendations?

[1]  J. Honnorat,et al.  Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes , 2021, Neurology: Neuroimmunology & Neuroinflammation.

[2]  M. Devine,et al.  Paraneoplastic neurological syndromes: clinical presentations and management , 2021, Therapeutic advances in neurological disorders.

[3]  A. Zaheer,et al.  ACR Appropriateness Criteria® Liver Lesion-Initial Characterization. , 2020, Journal of the American College of Radiology : JACR.

[4]  L. Eckel,et al.  Imaging Review of Paraneoplastic Neurologic Syndromes , 2020, American Journal of Neuroradiology.

[5]  J. Honnorat,et al.  Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[6]  Lin Li,et al.  EFFECTIVE RADIATION DOSE OF 18F-FDG PET/CT: HOW MUCH DOES DIAGNOSTIC CT CONTRIBUTE? , 2019, Radiation protection dosimetry.

[7]  G. Gigli,et al.  Epidemiology of paraneoplastic neurological syndromes: a population-based study , 2019, Journal of Neurology.

[8]  R. Nitrini,et al.  Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes , 2018, Current Oncology Reports.

[9]  A. Piersson,et al.  An audit of clinical practice, referral patterns, and appropriateness of clinical indications for brain MRI examinations: A single-centre study in Ghana. , 2017, Radiography.

[10]  W. Heindel,et al.  Imaging Workup of Suspected Classical Paraneoplastic Neurological Syndromes: A Systematic Review and Retrospective Analysis of 18F-FDG-PET-CT. , 2017, Academic radiology.

[11]  Masahiro Okada,et al.  Appropriate imaging utilization in Japan: a survey of accredited radiology training hospitals , 2017, Japanese Journal of Radiology.

[12]  R. Delgado-Bolton,et al.  18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  L. Pugliese,et al.  Inappropriateness of diagnostic imaging examinations in the inpatient setting: a case study research , 2017, La radiologia medica.

[14]  A. Venkatesan,et al.  A clinical approach to diagnosis of autoimmune encephalitis , 2016, The Lancet Neurology.

[15]  M. Reiser,et al.  Detection of underlying malignancy in patients with paraneoplastic neurological syndromes: comparison of 18F-FDG PET/CT and contrast-enhanced CT , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  M. Cristofaro,et al.  Appropriateness: analysis of outpatient radiology requests , 2012, La radiologia medica.

[17]  J. Honnorat,et al.  Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force , 2011, European journal of neurology.

[18]  J. Honnorat,et al.  Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. , 2010, Archives of neurology.

[19]  V. Lowe,et al.  Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. , 2008, Mayo Clinic proceedings.

[20]  T. Helmberger,et al.  Antibody-positive paraneoplastic neurologic syndromes , 2004, Neurology.

[21]  A. Freedman.  PARANEOPLASTIC DISORDERS , 1966, The Medical journal of Australia.